• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒核心区的多态性及其与肝细胞癌发生的关联。

Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma.

作者信息

Sedeno-Monge Virginia, Vallejo-Ruiz Veronica, Sosa-Jurado Francisca, Santos-Lopez Gerardo

机构信息

Departamento de Ciencias de la Salud, Universidad Popular Autonoma del Estado de Puebla, Puebla, Mexico.

出版信息

J Biosci. 2017 Sep;42(3):509-521. doi: 10.1007/s12038-017-9695-4.

DOI:10.1007/s12038-017-9695-4
PMID:29358564
Abstract

Little is known about the mechanisms underlying hepatocellular carcinoma (HCC). Some studies have focused on the role of HCV viral proteins in hepatocyte transformation. In this work we have compiled and analysed current articles regarding the impact of polymorphisms in the HCV core gene and protein on the development of HCC. An exhaustive search for fulltext articles until November 2016 in PubMed database was performed using the MeSH keywords: 'hepatitis C', 'polymorphisms', 'core', 'hepatocellular cancer' and 'hepatocarcinogenesis'. Nineteen full-text articles published between 2000 and 2016 were considered. Different articles associate not only the HCC development with polymorphisms at residues 70 and 91 in the core protein, but more with mortality and treatment response. Also, different polymorphisms were found in core and other viral proteins related to HCC development. Eleven articles reported that HCC development is significantly associated with Gln/His70, four associated it with Leu91 and two more associated it with both markers together. Additional studies are necessary, including those in different types of populations worldwide, to validate the possibility of the usability and influence in chronically HCV-infected patients as well as to observe their interaction with other risk factors or prognosis and genetic markers of the host.

摘要

关于肝细胞癌(HCC)的潜在机制,人们了解甚少。一些研究聚焦于丙型肝炎病毒(HCV)病毒蛋白在肝细胞转化中的作用。在这项工作中,我们收集并分析了当前有关HCV核心基因和蛋白多态性对HCC发生影响的文章。使用医学主题词(MeSH)关键词“丙型肝炎”“多态性”“核心”“肝细胞癌”和“肝癌发生”,在PubMed数据库中对截至2016年11月的全文文章进行了详尽检索。共纳入了2000年至2016年间发表的19篇全文文章。不同文章不仅将HCC的发生与核心蛋白70位和91位残基的多态性相关联,而且更多地与死亡率和治疗反应相关联。此外,在与HCC发生相关的核心蛋白及其他病毒蛋白中发现了不同的多态性。11篇文章报道HCC的发生与Gln/His70显著相关,4篇文章将其与Leu91相关联,另外2篇文章将其与这两个标记物均相关联。需要开展更多研究,包括针对全球不同人群的研究,以验证其在慢性HCV感染患者中的可用性和影响的可能性,并观察它们与其他危险因素或宿主的预后及遗传标记物之间的相互作用。

相似文献

1
Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma.丙型肝炎病毒核心区的多态性及其与肝细胞癌发生的关联。
J Biosci. 2017 Sep;42(3):509-521. doi: 10.1007/s12038-017-9695-4.
2
Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma.丙型肝炎病毒核心蛋白调节几种参与肝细胞癌的信号通路。
World J Gastroenterol. 2019 Jan 7;25(1):42-58. doi: 10.3748/wjg.v25.i1.42.
3
Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.丙型肝炎病毒 1b 基因型核心、NS3 和 NS5A 蛋白的多态性与肝细胞癌的发生有关。
Hepatology. 2013 Aug;58(2):555-63. doi: 10.1002/hep.26205. Epub 2013 Jun 14.
4
Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma.丙型肝炎病毒核心基因的突变与晚期肝病和肝细胞癌相关。
Clin Cancer Res. 2009 May 1;15(9):3205-13. doi: 10.1158/1078-0432.CCR-08-2418. Epub 2009 Apr 21.
5
A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.一种用于区分病毒核心基因中有无与肝癌相关突变的丙型肝炎病毒的细胞培养系统。
J Hepatol. 2015 Dec;63(6):1323-33. doi: 10.1016/j.jhep.2015.07.024. Epub 2015 Jul 26.
6
The core of hepatitis C virus pathogenesis.丙型肝炎病毒发病机制的核心。
Curr Opin Virol. 2016 Apr;17:66-73. doi: 10.1016/j.coviro.2016.01.009. Epub 2016 Feb 3.
7
Truncated hepatitis C virus core protein encoded in hepatocellular carcinomas.肝细胞癌中编码的截短型丙型肝炎病毒核心蛋白。
Int J Mol Med. 2004 Dec;14(6):1097-100.
8
Hepatocellular carcinoma: molecular interactions between hepatitis C virus and p53 in hepatocarcinogenesis.肝细胞癌:丙型肝炎病毒与p53在肝癌发生中的分子相互作用
Expert Rev Mol Med. 2003 Nov 19;5(28):1-16. doi: 10.1017/S1462399403006926.
9
Immunohistochemical detection of hcv in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR.采用平行组织定量逆转录聚合酶链反应对肝硬化、发育异常结节及肝细胞癌中的丙型肝炎病毒进行免疫组织化学检测。
Mod Pathol. 2001 May;14(5):496-505. doi: 10.1038/modpathol.3880338.
10
Compartmentalization of hepatitis C virus variants in patients with hepatocellular carcinoma.肝细胞癌患者中丙型肝炎病毒变体的区室化
Mol Carcinog. 2017 Feb;56(2):371-380. doi: 10.1002/mc.22500. Epub 2016 May 31.

引用本文的文献

1
Molecular mechanisms of viral oncogenesis in haematological malignancies: perspectives from metabolic reprogramming, epigenetic regulation and immune microenvironment remodeling.血液系统恶性肿瘤中病毒致癌作用的分子机制:代谢重编程、表观遗传调控及免疫微环境重塑视角
Exp Hematol Oncol. 2025 May 10;14(1):69. doi: 10.1186/s40164-025-00655-2.
2
Using host genetics to infer the global spread and evolutionary history of HCV subtype 3a.利用宿主遗传学推断丙型肝炎病毒3a亚型的全球传播及进化史。
Virus Evol. 2021 Jul 9;7(2):veab065. doi: 10.1093/ve/veab065. eCollection 2021.

本文引用的文献

1
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.直接作用抗病毒药物治疗的丙型肝炎相关肝硬化中肝细胞癌的早期发生和复发。
J Hepatol. 2016 Oct;65(4):727-733. doi: 10.1016/j.jhep.2016.06.015. Epub 2016 Jun 24.
2
Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts.直接作用抗病毒药物对肝细胞癌复发影响的证据不足:来自三个法国国家研究署队列的数据。
J Hepatol. 2016 Oct;65(4):734-740. doi: 10.1016/j.jhep.2016.05.045. Epub 2016 Jun 7.
3
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.
接受无干扰素治疗的丙型肝炎相关 HCC 患者早期肿瘤复发率高。
J Hepatol. 2016 Oct;65(4):719-726. doi: 10.1016/j.jhep.2016.04.008. Epub 2016 Apr 13.
4
Interferon lambda and hepatitis C virus core protein polymorphisms associated with liver cancer.与肝癌相关的λ干扰素和丙型肝炎病毒核心蛋白多态性
Virology. 2016 Jun;493:136-41. doi: 10.1016/j.virol.2016.03.008. Epub 2016 Mar 29.
5
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).用于丙型肝炎病毒基因3型和晚期肝病的达卡他韦、索磷布韦和利巴韦林:一项随机III期研究(ALLY-3+)
Hepatology. 2016 May;63(5):1430-41. doi: 10.1002/hep.28473. Epub 2016 Mar 4.
6
Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.免疫分析在慢性丙型肝炎病毒感染的无干扰素治疗期间揭示了自然杀伤细胞群的调节。
J Infect Dis. 2016 Jan 15;213(2):216-23. doi: 10.1093/infdis/jiv391. Epub 2015 Jul 28.
7
Impact of Mutations at Amino Acid 70 in Hepatitis C Virus (HCV) Genotype 1b Core Region on Hepatocarcinogenesis following Eradication of HCV RNA.丙型肝炎病毒(HCV)1b基因型核心区域第70位氨基酸突变对HCV RNA清除后肝癌发生的影响
J Clin Microbiol. 2015 Sep;53(9):3039-41. doi: 10.1128/JCM.01457-15. Epub 2015 Jul 1.
8
Substitution in Amino Acid 70 of Hepatitis C Virus Core Protein Changes the Adipokine Profile via Toll-Like Receptor 2/4 Signaling.丙型肝炎病毒核心蛋白70位氨基酸的替换通过Toll样受体2/4信号通路改变脂肪因子谱。
PLoS One. 2015 Jun 29;10(6):e0131346. doi: 10.1371/journal.pone.0131346. eCollection 2015.
9
Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.肝细胞癌诊断、治疗及预防的当前趋势与最新进展
Asian Pac J Cancer Prev. 2015;16(9):3595-604. doi: 10.7314/apjcp.2015.16.9.3595.
10
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.来迪派韦索磷布韦与利巴韦林联合治疗晚期肝病患者的 HCV 感染。
Gastroenterology. 2015 Sep;149(3):649-59. doi: 10.1053/j.gastro.2015.05.010. Epub 2015 May 15.